Adlai Pappy, MD
Anesthesiology · Boston, MANPI 1508326174
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 57.1% of the total. Reporting peaked in 2024 at $6,541 and has fallen 76.7% since, to $1,523 in 2025. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $99.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$4K
- Biotronik NRO, Inc.$681
- Stryker$307
- Averitas Pharma Inc.$301
- Nevro Corp.$201
- plus $223 from 3 others
What the payments were for
- Travel & lodging$6,83353%
- Food & beverage$6,00647%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 85 | $7,332 |
| Boston Scientific | 26 | $3,795 |
| Biotronik NRO, Inc. | 6 | $681 |
| Stryker | 3 | $307 |
| Averitas Pharma Inc. | 3 | $301 |
| Nevro Corp. | 3 | $201 |
| Teva Pharmaceuticals USA, Inc. | 1 | $139 |
| Si-bone, Inc. | 1 | $52 |
| AbbVie | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$3,353
- VANTA ADAPTIVESTIM$1,224
- Prospera$638
- WaveWriter Alpha Prime 16$577
- Qutenza$267
- ELEVATE SPINAL SYSTEM$173
- SPINEJACK$173
- Senza$145
- AJOVY$139
- INCEPTIV$131
- mild Device Kit$117
How this compares
$12,839 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 27 | $802 |
| Gabapentin | 52 | $722 |
| Oxycodone Hcl | 22 | $317 |
| Tizanidine Hcl | 11 | $251 |
| Methadone Hcl | 14 | $151 |
| Tramadol Hcl | 12 | $91 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Boston
- Douglas ShookBoston$267K
- Robert YongBoston$231K
- Michael DambraBoston$194K
- Robert TruogBoston$172K
- Mary Ellen McCannBoston$140K
- Stanton ShernanBoston$136K
- Edgar RossBoston$129K
- Sadeq QuraishiBoston$107K
- James PhilipBoston$56K
- Feroze Ud Din MahmoodBoston$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.